Clemens Schumm studied Biosciences in his Bachelors program as well as molecular Biosciences in his masters at the Goethe-University Frankfurt/Main. He graduated in 2021 and completed his studies with his master thesis about the transcriptional regulation of the carnitindegradation in A. baumannii ATCC 19606. During his program he specialized in transcriptional regulatory processes.

Since January 2022 he is part of the Group Microbial Natural Products as a Ph.D. candidate. His work is focusing on the characterization and production of new bioactive secondary metabolites from myxo- and actinobacteria which are identified among others by Genome Mining.

Furthermore he is working on ribosomally translated and posttranslational modified peptides (RiPPs) that were identifies in actinobacteria as well as in myxobacteria.